Crossmark

Exercise as a supportive care strategy in men with prostate cancer receiving androgen deprivation therapy at a regional cancer centre: a survey of patients and clinicians

Crossref DOI link: https://doi.org/10.1007/s00520-021-06512-2

Published Online: 2021-09-14

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elbourne, Hugh

Soo, Wee Kheng

O’Reilly, Victoria

Moran, Anna

Steer, Christopher B. https://orcid.org/0000-0002-7677-3339
License Information

Text and Data Mining valid from 2021-09-14

Version of Record valid from 2021-09-14
More Information

Article History

Received: 11 May 2021

Accepted: 21 August 2021

First Online: 14 September 2021

Declarations

:

: Trial approved by Albury Wodonga Health HREC ERM/4800 (AWHREC 442/18/9).

: Informed consent gained from all participants.

: Informed consent gained from all participants.

: Dr. Christopher Steer has received honoraria for advisory board membership and speakers’ fees from Astra Zeneca, Glaxo Smith Kline, Specialised Therapeutics, Eisai, Janssen, MSD, Merck and Roche. HE, WKS, VO and AM declare no competing interests.

Document is current

Any future updates will be listed below